iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF) Shares Down 0.1% – Should You Sell?

iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF – Get Free Report)’s stock price traded down 0.1% during mid-day trading on Monday. The company traded as low as $41.04 and last traded at $41.04. 20,150 shares were traded during trading, an increase of 48% from the average daily volume of 13,572 shares. The stock had previously closed at $41.10.

iShares LifePath Target Date 2050 ETF Stock Performance

The stock has a 50-day moving average of $41.88 and a 200-day moving average of $40.30. The firm has a market cap of $99.32 million, a price-to-earnings ratio of 20.56 and a beta of 0.87.

Institutional Trading of iShares LifePath Target Date 2050 ETF

An institutional investor recently bought a new position in iShares LifePath Target Date 2050 ETF stock. Integrated Wealth Concepts LLC acquired a new position in iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 29,061 shares of the company’s stock, valued at approximately $1,206,000. Integrated Wealth Concepts LLC owned approximately 1.42% of iShares LifePath Target Date 2050 ETF as of its most recent SEC filing.

About iShares LifePath Target Date 2050 ETF

(Get Free Report)

The iShares LifePath Target Date 2050 ETF USD (ITDF) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2050. ITDF was launched on Oct 17, 2023 and is issued by BlackRock.

Recommended Stories

Receive News & Ratings for iShares LifePath Target Date 2050 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2050 ETF and related companies with MarketBeat.com's FREE daily email newsletter.